Mazagon Dock Shipbuilders: Presents Q2 FY27 Financial Performance

Mazagon Dock Shipbuilders Limited has released its investor presentation detailing the company’s financial performance for the quarter and half-year ended September 30, 2026. The presentation covers key financial metrics for both standalone and consolidated operations, including revenue from operations, total income, EBITDA, PBT, PAT, and Net Worth. This disclosure provides stakeholders with essential information regarding the company’s operational achievements and financial standing for the specified periods.

Investor Presentation Released

Mazagon Dock Shipbuilders Limited (MDL) has uploaded its Corporate Investors Presentation on the company’s website, detailing its performance for the quarter and period ended September 30, 2026. The presentation serves as a comprehensive update for investors on the company’s financial and operational achievements during this period.

Key Financial Highlights (Standalone)

Quarterly Performance (Q2 FY 2026-27 vs Q1 FY 2026-27 vs Q2 FY 2025-26)

  • Revenue from Operation: Increased from ₹2,228 Cr in Q2-2026-2027 to ₹2,771 Cr in Q1-2026-2027 and ₹2,929 Cr in Q2-2025-2026.
  • Total Income: Showed growth from ₹2,525 Cr in Q2-2026-2027 to ₹3,061 Cr in Q1-2026-2027 and ₹3,206 Cr in Q2-2025-2026.
  • EBITDA: Rose from ₹476 Cr in Q2-2026-2027 to ₹723 Cr in Q1-2026-2027 and ₹971 Cr in Q2-2025-2026.
  • PBT: Recorded ₹442 Cr in Q2-2026-2027, ₹684 Cr in Q1-2026-2027, and ₹939 Cr in Q2-2025-2026.
  • PAT: Stood at ₹340 Cr in Q2-2026-2027, ₹510 Cr in Q1-2026-2027, and ₹715 Cr in Q2-2025-2026.
  • Net worth: Was ₹9,510 Cr in Q2-2026-2027, ₹9,353 Cr in Q1-2026-2027, and ₹8,083 Cr in Q2-2025-2026.

Half Yearly Performance (H1 FY 2026-27 vs H1 FY 2025-26)

  • Revenue from Operation: Reported ₹4,999 Cr for H1 2026-2027 compared to ₹5,555 Cr for H1 2025-2026.
  • Total Income: Was ₹5,585 Cr for H1 2026-2027 and ₹6,156 Cr for H1 2025-2026.
  • EBITDA: Recorded ₹1,199 Cr for H1 2026-2027 and ₹1,597 Cr for H1 2025-2026.
  • PBT: Was ₹1,126 Cr for H1 2026-2027 and ₹1,506 Cr for H1 2025-2026.
  • PAT: Stood at ₹850 Cr for H1 2026-2027 and ₹1,135 Cr for H1 2025-2026.
  • Net Worth: Was ₹9,510 Cr for H1 2026-2027 and ₹8,083 Cr for H1 2025-2026.

The order book as on 30th September 2026 is reported at ₹16,443 Cr.

Key Financial Highlights (Consolidated)

Quarterly Performance (Q2 FY 2026-27 vs Q1 FY 2026-27 vs Q2 FY 2025-26)

  • Revenue from Operation: Was ₹2,446 Cr in Q2-2026-2027, ₹2,943 Cr in Q1-2026-2027, and ₹2,929 Cr in Q2-2025-2026.
  • Total Income: Showed ₹2,697 Cr in Q2-2026-2027, ₹3,236 Cr in Q1-2026-2027, and ₹3,201 Cr in Q2-2025-2026.
  • EBITDA: Recorded ₹450 Cr in Q2-2026-2027, ₹740 Cr in Q1-2026-2027, and ₹966 Cr in Q2-2025-2026.
  • PBT: Stood at ₹399 Cr in Q2-2026-2027, ₹686 Cr in Q1-2026-2027, and ₹934 Cr in Q2-2025-2026.
  • PAT: Was ₹346 Cr in Q2-2026-2027, ₹550 Cr in Q1-2026-2027, and ₹749 Cr in Q2-2025-2026.
  • Net worth: Was ₹10,684 Cr in Q2-2026-2027, ₹10,504 Cr in Q1-2026-2027, and ₹8,910 Cr in Q2-2025-2026.

Half Yearly Performance (H1 FY 2026-27 vs H1 FY 2025-26)

  • Revenue from Operation: Was ₹5,389 Cr for H1 2026-2027 and ₹5,555 Cr for H1 2025-2026.
  • Total Income: Was ₹5,933 Cr for H1 2026-2027 and ₹6,150 Cr for H1 2025-2026.
  • EBITDA: Recorded ₹1,190 Cr for H1 2026-2027 and ₹1,592 Cr for H1 2025-2026.
  • PBT: Was ₹1,086 Cr for H1 2026-2027 and ₹1,501 Cr for H1 2025-2026.
  • PAT: Stood at ₹897 Cr for H1 2026-2027 and ₹1,202 Cr for H1 2025-2026.
  • Net Worth: Was ₹10,684 Cr for H1 2026-2027 and ₹8,910 Cr for H1 2025-2026.

Source: BSE

Previous Article

MedPlus Health: Q2 FY27 Consolidated Revenue ₹20,371 Million